Innovative Models for the Empowerment of Patients with Type 2 Diabetes: The CAIPaDi Program

Title:Innovative Models for the Empowerment of Patients with Type 2 Diabetes: The CAIPaDi Program

Volume: 8 Issue: 3

Author(s): Sergio Hernandez-Jimenez, Cristina Garcia-Ulloa, Roopa Mehta, Carlos A. Aguilar-Salinas and David Kershenobich-Stalnikowitz

Affiliation:

Keywords: Chronic care model, empowerment, Mexico, prevention, self-management, type 2 diabetes.

Abstract: Empowerment interventions for chronic diseases are an evolving process. No agreement exists regarding the necessary components and methodologies to be applied. Systematic reviews have assessed the effect of self-management interventions. Improvements in illness beliefs, adherence to drug therapy and glucose monitoring have been reported. In the long term, no major changes have been achieved in weight, physical activity, smoking status, and depression scores. There is a need for additional studies. The CAIPaDi (Centro de Atención Integral del Paciente con Diabetes) program is an intervention designed to provide education and empowerment techniques (using simple low-cost interactive tools) over a short period of time followed by at-distance support using internet or cell phone technology. The target population consists of patients with type 2 diabetes, free of chronic complications who are non-smokers. The intervention is composed of four monthly visits followed by a continuous at-distance support system. At each visit, patients stay for six hours in the center. Information is presented in group sessions. Empowerment techniques are applied during individual exchanges with the team or during facilitated group sessions. In summary, empowerment programs are an unmet need in many healthcare services. This review also discusses relevant studies and patents in the management of type 2 diabetes.

Cite this article as:

Hernandez-Jimenez Sergio, Garcia-Ulloa Cristina, Mehta Roopa, Aguilar-Salinas A. Carlos and Kershenobich-Stalnikowitz David, Innovative Models for the Empowerment of Patients with Type 2 Diabetes: The CAIPaDi Program, Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) 2014; 8 (3) . https://dx.doi.org/10.2174/1872214808999141110155515